SynthesisFrontiers in oncology2023

Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review.

Edward B Garon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.